Plate Nº 11 · recorded October 10, 2026
Biology & EvolutionReported finding
Staph Bacteria Grows Three Times Thicker Cell Wall in Milk, Study Finds
Staphylococcus aureus grown in milk builds a cell wall about three times thicker than usual, French researchers report, making the pathogen much harder to kill with mastitis antibiotics.
By James Calloway3 min read568 words
In brief
- S. aureus grown in milk develops a cell envelope about three times thicker than the same strain grown in serum.
- The study was published in Communications Biology in 2026 (DOI: 10.1038/s42003-026-10771-2).
- Lead author Vincent Léguillier and colleagues showed milk-grown bacteria resisted multiple antibiotics used to treat mastitis.
- Thicker walls come from S. aureus incorporating host milk lipids instead of making its own, which also boosts the protective golden pigment.
- The team is developing combination therapies that pair an antibiotic with a molecule blocking lipid scavenging.
Staphylococcus aureus builds a cell envelope roughly three times thicker when it grows in milk than in blood serum, according to experiments published in Communications Biology. The thicker wall makes the bacterium harder to kill with the antibiotics veterinarians and doctors use against mastitis, a common mammary-gland infection.
The study, led by Vincent Léguillier and colleagues, appeared in the journal in 2026 under the title "Biotope-dependent resistance to reactive oxygen species, antibiotic tolerance, and virulence of Staphylococcus aureus."
What did the researchers compare?
S. aureus can cause very different diseases depending on where it lands in the body. To capture that variability in the lab, the team grew the same strain in two settings that mirror real infections:
- Milk, which surrounds the bacterium during bovine and human mastitis
- Serum, the fluid component of blood, where S. aureus lives during many systemic infections
The contrast let the researchers isolate how the surrounding environment reshapes a single bacterial species.
How does milk change the bacterium?
Milk is rich in fats, and S. aureus borrows them. Instead of synthesizing its own lipids, the microbe folds host milk fats directly into its outer envelope. The result is a cell wall about three times thicker than the wall of bacteria raised in serum or standard laboratory broth.
The borrowed lipids also amplify the production of staphyloxanthin, the golden pigment that gives S. aureus its name and its aureus species label. That pigment acts as an antioxidant, soaking up reactive oxygen species that immune cells and some antibiotics use to damage bacterial cells.
Vincent Léguillier's team reported that milk-grown S. aureus showed higher resistance to oxidative stress than serum-grown cells, matching the stronger pigment shield.
Why does this matter for antibiotic treatment?
Front-line mastitis drugs work by disrupting the bacterial envelope or generating oxidative stress. The same thickening that shields the cell from oxidative damage also physically blocks antibiotics from reaching their targets.
The researchers tested the antibiotics commonly prescribed for mastitis and found that S. aureus raised in milk survived them far better than the same strain raised in serum. The team tied this resilience to two linked changes: a thicker envelope and a stronger antioxidant defense.
The findings do not change the basic antibiotic classes used in mastitis, but they do suggest that doses or combinations chosen by lab testing may underestimate the real challenge inside a milk-filled mammary gland.
What does it mean for people and dairy farms?
Mastitis hits dairy cows hard, lowering milk yields and forcing farmers to use large quantities of antibiotics. The same infection affects breastfeeding women, where antibiotic choices are narrower and consequences for infants weigh heavily.
The paper argues that treatment protocols may need adjustment when milk is plentiful, in both animals and humans. A drug that looks effective in a lab dish may fail in the udder.
What comes next?
The group is now testing combination therapies. The plan pairs a standard antibiotic with a helper molecule that blocks S. aureus from scavenging lipids from its host. Without the borrowed fats, the bacterium cannot build its fortified envelope, and existing drugs may work as designed.
Researchers will need larger animal trials and clinical data before any new protocol reaches a clinic or a dairy barn. The authors frame the work as a starting point for tailoring antibiotic regimens to the specific biotope where an infection takes hold.
via Phys.org Biology (Source)
More from James Calloway
Show full bio
Staff writer covering marketplaces and e-commerce at SciBeat.
205 articles
Nearby plates
- Common Mouth Bacterium Trains Lungs to Fight Pneumonia, Study Finds
- 160-Million-Year-Old Peptides Outperform Modern Human Versions
- Skipping Sweets During Antibiotic Treatment May Protect Gut Microbiome
- Two Protein Plugs Help Superbug P. aeruginosa Block Antibiotics
- Why a Food Poisoning Bacterium Can Also Cause Severe Wound Infections